Skip to content
Screener

AngioDynamics ANGO Retained Earnings

Retained Earnings at other companies

Abbott logo
AbbottABT
$49.79B+2.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$17.39B+7.7%
TFX
TeleflexTFX
$3.15B-23.5%
Stryker logo
StrykerSYK
$20.88B+10.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$865.03M+19.2%
ICU Medical logo
ICU MedicalICUI
$740.11M+4.2%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
Line itemMay 31, 2026May 31, 2025
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively387385
Additional paid-in capital636,083621,186
Accumulated deficit(465,939)(429,197)
Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively(7,381)(7,381)
Accumulated other comprehensive loss7,675(2,023)
Total Stockholders' Equity170,825182,970
Total Liabilities and Stockholders' Equity$267,163$280,144

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's retained earnings?
AngioDynamics (ANGO) reported retained earnings of -$465.94M in Q1 2026.
How has AngioDynamics's retained earnings changed year-over-year?
AngioDynamics's retained earnings decreased by 8.6% year-over-year, from -$429.2M to -$465.94M.
What is the long-term trend for AngioDynamics's retained earnings?
Over 5 years (2021 to 2026), AngioDynamics's retained earnings has grown at a 28.7% compound annual growth rate (CAGR), from -$131.87M to -$465.94M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about AngioDynamics's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude